| Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer J Ogier du Terrail, A Leopold, C Joly, C Béguier, M Andreux, C Maussion, ... Nature medicine 29 (1), 135-146, 2023 | 69 | 2023 |
| Collaborative federated learning behind hospitals’ firewalls for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer JO Du Terrail, A Leopold, C Joly, C Beguier, M Andreux, C Maussion, ... medRxiv, 2021.10. 27.21264834, 2021 | 9 | 2021 |
| Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial L Delrieu, AS Hamy, F Coussy, A Kassara, B Asselain, J Antero, ... BMC cancer 22 (1), 493, 2022 | 3 | 2022 |
| Collaborative federated learning behind hospitals’ firewalls for predicting histological complete response to neoadjuvant chemotherapy in triple-negative breast cancer. J Ogier du Terrail, A Leopold, C Joly, M Andreux, C Maussion, ... Journal of Clinical Oncology 40 (16_suppl), 590-590, 2022 | 1 | 2022 |
| Abstract CT231: Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy L Delrieu, AS Hamy, F Coussy, A Kassara, B Asselain, J Antero, ... Cancer Research 82 (12_Supplement), CT231-CT231, 2022 | | 2022 |
| Collaborative Federated Learning behind Hospitals' Firewalls for Predicting Histological Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer J Ogier du Terrail, A Leopold, C Joly, C Beguier, M Andreux, C Maussion, ... | | 2021 |
| Wearable Computing I RAICU, M MUNHOVEN, A LEOPOLD | | 2016 |
